Page 5 - Biomaster Healthcare Catalogue v2
P. 5
The healthcare estate accounts for a signi cant portion of NHS spending. With a direct cost of £7 billion per annum, it is the third largest expenditure after staff and drugs.
Specifying materials containing Biomaster
technology will reduce operational risk,
helping protect product surfaces against
microbial infection and making the NHS
less expensive for patients and clinicians.
EASY TO SPECIFY -
FIND OUT HOW
